These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20648587)

  • 41. Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer.
    Posner MC; Gooding WE; Lew JI; Rosenstein MM; Lembersky BC
    Surgery; 2001 Oct; 130(4):620-6; discussion 626-8. PubMed ID: 11602892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.
    Smit JK; Güler S; Beukema JC; Mul VE; Burgerhof JG; Hospers GA; Plukker JT
    Ann Surg Oncol; 2013 Nov; 20(12):4008-15. PubMed ID: 23838922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy.
    Kim MK; Kim SB; Ahn JH; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HY; Shin JH; Cho KJ; Ryu JS; Park SI
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):725-34. PubMed ID: 18164836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of immunohistochemically detected lymph node micrometastases in pT0N0 esophageal squamous cell carcinoma.
    Chao YK; Yeh CJ; Chuang WY; Fan KH; Hsieh MJ; Chu Y; Cheng AJ; Liu HP
    J Surg Oncol; 2009 Dec; 100(7):559-62. PubMed ID: 19653242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
    Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
    Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Squamous cell carcinoma of the esophagus: multimodal therapy in locally advanced disease.
    El Nakadi I; Van Laethem JL; Houben JJ; Gay F; Closset J; Van Houtte P; Danhier S; Limbosch JM; Lambilliotte JP; Gelin M
    World J Surg; 2002 Jan; 26(1):72-8. PubMed ID: 11898037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic variables in thoracic esophageal squamous cell carcinoma.
    Lin CS; Chang SC; Wei YH; Chou TY; Wu YC; Lin HC; Wang LS; Hsu WH
    Ann Thorac Surg; 2009 Apr; 87(4):1056-65. PubMed ID: 19324127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.
    Bruzzi JF; Swisher SG; Truong MT; Munden RF; Hofstetter WL; Macapinlac HA; Correa AM; Mawlawi O; Ajani JA; Komaki RR; Fukami N; Erasmus JJ
    Cancer; 2007 Jan; 109(1):125-34. PubMed ID: 17146785
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Total number of resected lymph nodes predicts survival in esophageal cancer.
    Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
    Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma.
    Chao YK; Yeh CJ; Chang HK; Tseng CK; Chu YY; Hsieh MJ; Wu YC; Liu HP
    Ann Surg Oncol; 2011 Feb; 18(2):529-34. PubMed ID: 20697822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
    Yano T; Muto M; Minashi K; Onozawa M; Nihei K; Ishikura S; Kaneko K; Ohtsu A
    Endoscopy; 2011 Aug; 43(8):657-63. PubMed ID: 21623555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retrospective review of patients with locally advanced esophageal cancer treated at the University of Pittsburgh.
    Defoe SG; Pennathur A; Flickinger JC; Heron DE; Gibson MK; Luketich JD; Greenberger JS
    Am J Clin Oncol; 2011 Dec; 34(6):587-92. PubMed ID: 22101387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymph node dissection after chemoradiation in esophageal cancer: a subgroup analysis of patients with and without pathological response.
    Chao YK; Liu HP; Hsieh MJ; Wu YC; Liu YH; Yeh CH; Chang HK; Tseng CK
    Ann Surg Oncol; 2012 Oct; 19(11):3500-5. PubMed ID: 22622470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy.
    Law S; Kwong DL; Kwok KF; Wong KH; Chu KM; Sham JS; Wong J
    Ann Surg; 2003 Sep; 238(3):339-47; discussion 347-8. PubMed ID: 14501500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The number of pathologic lymph nodes involved is still a significant prognostic factor even after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma.
    Akutsu Y; Shuto K; Kono T; Uesato M; Hoshino I; Shiratori T; Isozaki Y; Akanuma N; Uno T; Matsubara H
    J Surg Oncol; 2012 Jun; 105(8):756-60. PubMed ID: 22162007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of prognosis after trimodal therapy in patients with locally advanced squamous cell carcinoma of the oesophagus.
    Stahl M; Lehmann N; Walz MK; Stuschke M; Wilke H
    Eur J Cancer; 2012 Nov; 48(16):2977-82. PubMed ID: 22503151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.